Emitac has partnered with Vancouver-based med-tech company Cognetivity Neurosciences as their authorized distributor in the Middle East for CognICA, Cognetivity’s flagship medical device product.
CognICA is an FDA-registered and CE-marked cutting-edge solution that provides computerized test of cognitive function with numerous advantages over traditional pen-and-paper examinations, such as its short testing duration and high classification accuracy, coupled with the absence of a learning effect or any cultural or educational bias. Cognetivity is developing products to support the early detection of dementia and is looking at incorporating AI in its solutions.
